Statute Details
- Title: Medicines (Cessation of Application of Act to Oral Dental Gums) Order 2016
- Act Code: MA1975-S542-2016
- Legislative Type: Subsidiary Legislation (SL)
- Authorising Act: Medicines Act (Cap. 176), section 77
- Legislative Instrument No.: S 542/2016
- Made Date: 31 October 2016
- Key Commencement/Effective Date: 1 November 2016
- Key Definitions: “oral dental gum”, “Oral Dental Gums Regulations”, “product licence”, “registrant”
- Key Provisions: Section 3 (cessation), Section 4 (saving and transitional provisions)
What Is This Legislation About?
The Medicines (Cessation of Application of Act to Oral Dental Gums) Order 2016 (“the Order”) is a targeted regulatory “switch” that changes the legal framework governing oral dental gums in Singapore. In practical terms, it stops the Medicines Act from applying to oral dental gums from 1 November 2016, and it transitions affected products and licence holders into the newer regime under the Health Products Act and the Health Products (Oral Dental Gums) Regulations 2016.
Oral dental gums are a specific category of products intended to promote dental health or oral hygiene. The Order defines this category carefully, including the types of gums covered and excluding certain gums manufactured or imported solely for research and development by appropriately registered persons. The regulatory change reflects a policy decision to treat oral dental gums as health products rather than medicines, aligning licensing, registration, and compliance duties with the Health Products framework.
For practitioners, the Order is less about substantive product standards and more about regulatory continuity: it ensures that licences and approvals granted under the Medicines Act do not simply disappear on the effective date. Instead, the Order provides a structured set of deeming provisions so that existing licences and import/manufacturing/wholesale permissions continue under the Health Products regime.
What Are the Key Provisions?
Section 1 (Citation) identifies the instrument as the “Medicines (Cessation of Application of Act to Oral Dental Gums) Order 2016”. This is standard but important for legal referencing.
Section 2 (Definitions) sets the boundaries of the Order. The most significant definition is “oral dental gum”. It means any chewing gum (or similar substance) prepared from a gum base of vegetable or synthetic origin and intended to be chewed to promote dental health or oral hygiene. The definition also includes an explicit exclusion: it does not include gums manufactured or imported into Singapore solely for research and development purposes by a person registered under the Control of Manufacture Act (Cap. 57) in respect of the manufacture of chewing gum. This exclusion matters because it prevents the Order’s cessation and transitional mechanics from being applied to R&D-only activities.
Section 2 also defines “Oral Dental Gums Regulations” as the Health Products (Oral Dental Gums) Regulations 2016 (G.N. No. S 539/2016). This signals that the Health Products Regulations will govern compliance duties after the switch. It defines “product licence” by reference to the Medicines Act (section 5(1)), and defines “registrant” as a person who has applied for and obtained registration of the oral dental gum under the Health Products Act (Cap. 122D). These definitions are essential because the transitional provisions repeatedly “deem” licence holders into the status of registrants or licence holders under the new regime.
Section 3 (Cessation of application of Act) is the core operative provision. It provides that the provisions of the Medicines Act cease to apply to any oral dental gum as from 1 November 2016. This is a clean legal discontinuity: after that date, oral dental gums are no longer regulated as medicines under the Medicines Act. Instead, they fall within the Health Products framework.
Section 4 (Saving and transitional provisions) is the most practically important part for affected businesses. It ensures continuity for products and licence holders that were valid immediately before the effective date. The section operates through a series of deeming rules:
(1) Deemed registration of existing product licence holders. Every oral dental gum for which a product licence is valid immediately before 1 November 2016 is deemed, on or after that date and for so long as the product licence remains valid, to be registered as an oral dental gum under the Health Products Act. This means that the product does not lose regulatory status merely because the legal regime changes. The “for so long as the product licence remains valid” limitation is critical: the deeming effect is not indefinite.
(2) Deemed registrant status and duties. On or after 1 November 2016, the holder of the product licence mentioned in subsection (1) is deemed to be a registrant and is subject to the duties of a registrant under the Health Products Act and the Oral Dental Gums Regulations. This is a major compliance shift: even though the product is deemed registered, the legal duties now attach to the holder under the new regime. Practitioners should treat this as a trigger for reviewing compliance obligations (e.g., regulatory reporting, quality and safety responsibilities, and any specific obligations under the Oral Dental Gums Regulations).
(3) Import licences: deemed to be importer’s licences. Every import licence under the Medicines Act for the import of an oral dental gum that is valid immediately before 1 November 2016 is treated, on or after that date and for so long as it remains valid, as if it were an importer’s licence under section 13 of the Health Products Act. This preserves the ability to import without requiring an immediate re-application solely due to the legislative switch.
(4) Manufacturer’s licences: deemed to be manufacturer’s licences under the Health Products Act. Similarly, every manufacturer’s licence granted under the Medicines Act for an oral dental gum that is valid immediately before 1 November 2016 is treated as if it were a manufacturer’s licence under section 12 of the Health Products Act.
(5) Wholesale dealer’s licences: deemed to be wholesaler’s licences. Every wholesale dealer’s licence granted under the Medicines Act that is valid immediately before 1 November 2016 is treated as if it were a wholesaler’s licence under section 14 of the Health Products Act.
(6) Deemed licence holders and ongoing duties. On or after 1 November 2016, the holder of any import, manufacturer’s, or wholesale dealer’s licence mentioned in subsections (3) to (5) is deemed, for so long as the licence remains valid, to be the holder of the corresponding licence under the Health Products Act and is subject to the duties of that licence holder under the Health Products Act and the Oral Dental Gums Regulations. This subsection is the “duties bridge”: it ensures that the new regulatory responsibilities apply immediately, not only at the time of licence renewal.
Finally, the Order includes the formal making clause: it was made on 31 October 2016 by the Permanent Secretary, Ministry of Health, Singapore, with reference to internal file numbers. While not substantive, it confirms the instrument’s validity and administrative provenance.
How Is This Legislation Structured?
The Order is short and structured around four provisions:
Section 1 provides the citation. Section 2 sets out definitions that determine the scope of “oral dental gum” and the meaning of key terms used in the Order. Section 3 contains the main cessation rule—when the Medicines Act stops applying to oral dental gums. Section 4 provides saving and transitional provisions, including multiple deeming rules for product licences, import licences, manufacturer’s licences, and wholesale dealer’s licences, and it expressly links these to the duties under the Health Products Act and the Oral Dental Gums Regulations.
Who Does This Legislation Apply To?
The Order applies to oral dental gums as defined in section 2, and to the persons who hold relevant permissions under the Medicines Act immediately before 1 November 2016. In practice, this includes:
(i) holders of product licences for oral dental gums; (ii) holders of import licences for oral dental gums; (iii) holders of manufacturer’s licences for oral dental gums; and (iv) holders of wholesale dealer’s licences for oral dental gums.
After the effective date, those persons are deemed to be registrants (for product registration) and deemed licence holders under the Health Products Act, and they become subject to the duties under the Health Products Act and the Oral Dental Gums Regulations. The Order therefore has direct operational impact on regulatory compliance teams, importers, manufacturers, wholesalers, and product owners.
Why Is This Legislation Important?
Although the Order is brief, it is legally significant because it effects a regulatory regime change with immediate consequences. The cessation of the Medicines Act’s application could have created uncertainty about product status, licence validity, and compliance obligations. Instead, the Order uses deeming provisions to preserve continuity and reduce disruption to legitimate market activity.
For practitioners, the key importance lies in the compliance transition. Section 4 does not merely preserve licences; it also imposes the duties of registrants and licence holders under the Health Products Act and the Oral Dental Gums Regulations. This means that businesses that were previously structured around Medicines Act compliance must ensure their governance, documentation, and regulatory processes align with the Health Products framework.
From an enforcement and risk perspective, the Order’s deeming rules can affect how regulators interpret non-compliance. For example, if a business fails to meet a duty that applies to registrants or licence holders under the Health Products Act, the business cannot rely on the argument that it is “still under the old Medicines Act regime,” because the Order explicitly deems the new status and duties from 1 November 2016.
Related Legislation
- Medicines Act (Cap. 176) — authorising provision: section 77; cessation relates to the Act’s application to oral dental gums
- Health Products Act (Cap. 122D) — registration and licensing framework for oral dental gums (including sections referenced in the Order)
- Health Products (Oral Dental Gums) Regulations 2016 (G.N. No. S 539/2016) — regulatory duties and requirements for registrants and licence holders
- Control of Manufacture Act (Cap. 57) — relevant to the R&D exclusion in the definition of “oral dental gum”
Source Documents
This article provides an overview of the Medicines (Cessation of Application of Act to Oral Dental Gums) Order 2016 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.